Aims: To evaluate whether baseline symptoms and outcomes are influenced by gender in a matched cohort undergoing neuromodulation.
Methods: Patients in our prospective neuromodulation database that had a tined lead placed were reviewed. Those that had implantable pulse generator (IPG) placed were matched on age and urologic diagnosis.